Case Details
- Citation: [2018] SGCA 17
- Case Title: PT Sandipala Arthaputra and others v STMicroelectronics Asia Pacific Pte Ltd and others
- Court: Court of Appeal of the Republic of Singapore
- Decision Date: 06 April 2018
- Civil Appeal No: Civil Appeal No 106 of 2017
- Coram: Sundaresh Menon CJ; Judith Prakash JA; Steven Chong JA
- Judgment Author: Steven Chong JA (delivering the judgment of the court)
- Judges: Sundaresh Menon CJ, Judith Prakash JA, Steven Chong JA
- Plaintiff/Applicant (Appellants): PT Sandipala Arthaputra; Paulus Tannos; Catherine Tannos
- Defendant/Respondent (Respondents): STMicroelectronics Asia Pacific Pte Ltd; Oxel Systems Pte Ltd; Vincent Pierre Luc Cousin
- Legal Areas: Tort — Conspiracy; Contract — Breach
- Procedural History: Appeal from High Court decisions in [2017] SGHC 102 and [2017] SGHC 191
- Counsel for Appellants: Prem Gurbani, Govintharasah s/o Ramanathan and Shafkat Fahmid Sifat (Gurbani & Co LLC)
- Counsel for 1st and 3rd Respondents: Ong Tun Wei Danny, Yam Wern Jhien, Danitza Hon Cai Xia, Gan Eng Tong and Teo Li Ping, Annabelle (Rajah & Tann Singapore LLP)
- Counsel for 2nd Respondent: Davinder Singh SC, Jaikanth Shankar, Timothy Lin, Jaspreet Singh, Tan Ruo Yu and Low Wu Yang (Drew and Napier LLC)
- Judgment Length: 28 pages; 17,333 words
Summary
PT Sandipala Arthaputra and others v STMicroelectronics Asia Pacific Pte Ltd and others [2018] SGCA 17 arose out of a commercial dispute over the supply of microchips for use in Indonesia’s electronic identification card project (the “Project”). The appellant, Sandipala, had contracted with Oxel for the supply of 100 million microchips under a Supply Contract. The chips were manufactured by STMicroelectronics Asia Pacific Pte Ltd (“ST-AP”) and encoded with Oxel’s software. After delivery, the chips were found to be incompatible with the e-KTP cards system unless fundamental changes were made, which the Indonesian government did not approve. Sandipala sued for breach of express and implied terms of the Supply Contract; Oxel counterclaimed for breach, and also alleged that Sandipala and its directors conspired by unlawful means to cause Oxel loss.
The High Court dismissed Sandipala’s claims, allowed Oxel’s contractual claims, and found Sandipala and its directors liable in tort for conspiracy by unlawful means. On appeal, the Court of Appeal accepted that the contractual principles were largely settled, but focused on a more nuanced question: when can directors be held tortiously liable for conspiracy in relation to what is, in substance, a company’s contractual breach? The Court of Appeal emphasised that while a company can conspire with its director (even if the director is its alter ego), directors should not be exposed to tortious liability merely because they were involved in the company’s breach. The court therefore examined the proper legal basis for imposing tortious liability on directors in the context of contractual non-performance.
What Were the Facts of This Case?
Sandipala produces personalised electronic identification cards. Its directors, Mr Paulus Tannos and Ms Catherine Tannos (collectively, “the Tannoses”), were described as responsible for most, if not all, of the decisions involving Sandipala. The respondents included ST-AP, which sells microchips, and Oxel Systems Pte Ltd (“Oxel”), which supplies the software (operating system) for those chips. A further respondent, Mr Vincent Pierre Luc Cousin (“Mr Cousin”), was ST-AP’s country manager in Indonesia. The commercial relationship was therefore structured so that ST-AP provided the physical chip, Oxel provided the software encoding, and Sandipala used the completed chips to produce the physical e-KTP cards.
The dispute centred on a Supply Contract concluded on 9 November 2011 between Sandipala and Oxel. The Supply Contract was documented through a one-page signed acceptance of Oxel’s quotation and a one-page purchase order. Sandipala ordered a “committed quantity” of 100 million chips at US$0.60 per unit (total US$60 million), to be delivered in four quarterly batches. Sandipala paid a 20% down payment for the first batch. The chips were manufactured by ST-AP as ST23YR12 chips (the “ST chip”) and encoded with Oxel’s operating system software known as “PAC” (the “Oxel chips”).
Sandipala’s purpose for purchasing the chips was to fulfil obligations under a separate tender contract with the Indonesian government (the “Tender”), for production of e-KTP cards for all citizens. Sandipala was the only party in the appeal that directly participated in the Tender. It joined a consortium led by PNRI (Perum Percetakan Negara) to bid. Within the consortium, PNRI and Sandipala were responsible for producing the e-KTP cards, while other members handled other project segments such as training seminars and installing systems.
During the tender process, bidders had to submit two chips for evaluation, and the operating system masked onto each chip had to be an “open operating system” capable of being put into two specified chip types. In the consortium’s tender proposal, two chip types were specified: an NXP P308G0P3 chip (“the NXP chip”) and the ST chip manufactured by ST-AP. The Indonesian government then conducted proof of concept testing in May and June 2011. The parties disputed which chip type had been tested at Sandipala’s factory on 20 May 2011 (the “tender evaluation”). Sandipala’s position was that the ST chip with a compatible operating system was successfully tested and that ST-AP and/or Oxel had promised that identical chips would be supplied under the Supply Contract. The respondents’ position was that only the NXP chip was tested because the ST chip was not ready for testing at that time, and therefore they could not have promised supply of ST chips identical to those tested. The High Court preferred the respondents’ version.
What Were the Key Legal Issues?
The appeal raised two intertwined strands: first, the contractual dispute concerning breach of express and implied terms of the Supply Contract; and second, the tort claim for conspiracy by unlawful means against Sandipala and its directors. While the Court of Appeal noted that the contractual principles were “fairly settled,” the “interesting issue” concerned the tortious counterclaim, particularly the circumstances in which directors can be held liable in tort for conspiracy in relation to what is essentially a company’s contractual breach.
At the heart of the tort issue was the conceptual and doctrinal question of corporate attribution and conspiratorial liability. The court referred to academic commentary on whether two legal persons who share one and the same mind can conspire. The court accepted that it is no longer controversial that a company can conspire with its director to cause harm to a third party, even if the director is the company’s alter ego. However, the court stressed that most breaches by companies would necessarily involve directors, because companies act through directors. The legal issue was therefore not whether directors can ever be liable, but what legal basis justifies imposing tortious liability on directors for a company’s contractual breach without undermining the policy of allowing directors to make decisions without fear of unwarranted personal exposure.
How Did the Court Analyse the Issues?
The Court of Appeal began by framing the policy tension: directors must be free to make decisions on behalf of the company, and tortious liability should not be imposed merely because directors were involved in the company’s breach. The court recognised that if liability were imposed on directors simply for their involvement, it would lead to “the gravest and widest consequences,” echoing the warning in Said v Butt [1920] 2 KB 497. In other words, the law must draw a principled line between (i) ordinary corporate decision-making that results in contractual non-performance and (ii) conduct that is sufficiently wrongful and independently tortious to justify personal liability.
In analysing the conspiracy claim, the court treated the case as a useful opportunity to examine the proper legal basis for tortious liability on directors in respect of contractual breaches by the company. The court’s reasoning proceeded from the accepted proposition that a company and its director are separate legal persons and can, in principle, conspire. Yet the court also acknowledged that the typical scenario of contractual breach will involve directors’ knowledge and participation. Therefore, the court’s analysis focused on whether the elements of conspiracy by unlawful means were satisfied in a manner that went beyond attributing the company’s breach to the directors.
Although the provided extract does not reproduce the entire evidential discussion, the court’s approach can be understood from its emphasis on doctrinal limits. The court accepted that liability cannot be imposed on directors merely because they had “some involvement” in causing the breach. This indicates that the court required more than participation in the company’s decision-making; it required a basis to show that directors engaged in conduct that constituted unlawful means directed at causing loss to Oxel, and that such conduct could properly be characterised as tortious rather than merely contractual.
The court also implicitly addressed the evidential and legal difficulty of distinguishing between (a) a breach of contract arising from commercial risk allocation and (b) a tortious conspiracy involving unlawful means. In conspiracy by unlawful means, the unlawful means must be something more than the breach itself; otherwise, the tort would become a backdoor to convert contractual disputes into personal tort claims against directors. The court’s policy concern was that without a principled basis, directors would face tort actions whenever a company fails to perform, thereby distorting the contractual allocation of risk and remedies.
Accordingly, the Court of Appeal’s analysis can be read as setting out a structured approach: first, identify the wrongful act(s) alleged as “unlawful means”; second, assess whether those acts are properly attributable to the directors as separate tortious conduct rather than mere involvement in the company’s breach; and third, ensure that the conspiracy framework is not used to impose “wider” consequences than intended by the law of contract and tort. The court’s discussion of corporate alter ego and conspiratorial capacity served to confirm that directors are not categorically immune, but the court’s caution about “some involvement” served to prevent overextension.
What Was the Outcome?
On the appeal, the Court of Appeal upheld the High Court’s findings on the contractual dispute, including that Sandipala was liable for breach of the Supply Contract and that Oxel’s counterclaims were allowed. The court also upheld the tortious finding that Sandipala and the Tannoses were liable for conspiracy by unlawful means to cause Oxel economic loss, subject to the court’s clarified reasoning on the legal basis for directors’ tort liability in this context.
Practically, the outcome meant that Sandipala could not avoid contractual liability by framing the dispute as one of promised compatibility or tender evaluation assurances, and the directors could not escape personal exposure by arguing that their involvement was merely part of the company’s contractual breach. The court’s decision therefore reinforced both contractual accountability and the circumstances in which directors may be held tortiously liable where the conspiracy elements are properly made out.
Why Does This Case Matter?
PT Sandipala Arthaputra v STMicroelectronics Asia Pacific Pte Ltd [2018] SGCA 17 is significant for practitioners because it addresses a recurring commercial litigation problem: how to treat director involvement in corporate contractual breaches when a claimant seeks to plead tortious conspiracy. The Court of Appeal’s emphasis on the policy against unwarranted personal liability provides a doctrinal safeguard. It confirms that directors are not automatically liable simply because they are the directing mind behind the company’s actions.
At the same time, the case confirms that directors can be liable where the claimant can establish the tort elements—particularly conspiracy by unlawful means—in a way that identifies unlawful conduct beyond the breach itself. This is important for drafting and pleading. Claimants must carefully articulate what constitutes the unlawful means and how it is connected to the directors’ conduct, rather than relying on the fact of breach and director participation alone. Defendants, conversely, can use the court’s reasoning to argue that tort claims are impermissible attempts to repackage contractual non-performance.
For law students, the decision is also useful as an illustration of how Singapore courts reconcile corporate separateness with tortious attribution. The court’s discussion of the “company and its directors as co-conspirators” theme provides a conceptual framework for understanding when the law permits conspiracy allegations against directors, and when it demands a stricter legal basis to avoid turning every contractual dispute into a personal tort claim.
Legislation Referenced
- (No specific statutes were provided in the supplied judgment extract.)
Cases Cited
- [1920] 2 KB 497 (Said v Butt)
- [2005] SGHC 98
- [2015] SGHC 206
- [2017] SGHC 102
- [2017] SGHC 191
- [2018] SGCA 17
- [2018] SGHC 20
Source Documents
This article analyses [2018] SGCA 17 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.